GIARRATANO, TOMMASO
 Distribuzione geografica
Continente #
NA - Nord America 366
EU - Europa 75
AS - Asia 43
Totale 484
Nazione #
US - Stati Uniti d'America 366
IT - Italia 37
CN - Cina 25
FI - Finlandia 13
SG - Singapore 8
SE - Svezia 6
CZ - Repubblica Ceca 5
HK - Hong Kong 5
IE - Irlanda 4
ES - Italia 3
GB - Regno Unito 3
IN - India 3
BE - Belgio 2
CH - Svizzera 1
DE - Germania 1
IR - Iran 1
JP - Giappone 1
Totale 484
Città #
Chandler 82
Fairfield 41
Ashburn 34
Woodbridge 23
Ann Arbor 22
Cambridge 18
Wilmington 17
Houston 15
Seattle 15
Helsinki 12
Padova 11
Beijing 7
Medford 7
Princeton 7
San Diego 7
New York 6
Codogno 5
Olomouc 5
Roxbury 5
Singapore 5
Des Moines 4
Dublin 4
Turin 4
Barcelona 3
London 3
Avezzano 2
Bergamo 2
Boardman 2
Brussels 2
Caserta 2
Changsha 2
Guangzhou 2
Nanjing 2
Perugia 2
Pune 2
Washington 2
Apiro 1
Decatur 1
Hefei 1
Jinan 1
Lappeenranta 1
Los Angeles 1
Norwalk 1
Piove Di Sacco 1
Redwood City 1
Rockville 1
Taiyuan 1
Tehran 1
Tokyo 1
Zurich 1
Totale 398
Nome #
Androgen receptor expression and association with distant disease-free survival in triple negative breast cancer: Analysis of 263 patients treated with standard therapy for stage I-III disease 120
Use of scalp-cooling device to prevent alopecia for breast cancer patients receiving chemotherapy: a single-Institution prospective study 84
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer 63
Erbb2 mrna expression and response to ado-trastuzumab emtansine (T-dm1) in her2-positive breast cancer 55
Evolution of HER2-low expression from primary to recurrent breast cancer 55
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases 47
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment 32
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1 32
Cardiac Safety of Adjuvant Trastuzumab and Paclitaxel for HER2+ early breast cancer patients published in Abstract Book of the 21th National Congress of Italian Association of Medical Oncology (AIOM) 25-27 October, 2019 - Rome, Italy Abstracts 13
Totale 501
Categoria #
all - tutte 2.804
article - articoli 2.461
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.265


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202058 0 0 1 9 5 2 8 8 6 11 5 3
2020/202194 1 2 6 7 1 21 10 5 23 6 4 8
2021/202288 1 0 3 1 16 6 12 4 11 3 4 27
2022/2023143 23 21 9 19 11 20 7 6 21 0 6 0
2023/2024118 14 12 11 10 14 17 8 6 1 7 6 12
Totale 501